The objective of this study is to examine the effects of eproxindine hydrochloride on VPC suppression when given as a single IV 20 minute infusion of 50-100 mg to patients with chronic stable ventricular premature complexes and to examine the safety and tolerance of eproxindine hydrochloride when given intravenously to patients.
Showing the most recent 10 out of 426 publications